Advanced Medical Solutions Group plc (LON:AMS) Announces Dividend of GBX 1.83

Advanced Medical Solutions Group plc (LON:AMS - Get Free Report) declared a dividend on Wednesday, March 19th, DividendData.Co.Uk reports. Investors of record on Thursday, May 29th will be given a dividend of GBX 1.83 ($0.02) per share on Friday, June 20th. This represents a yield of 0.89%. The ex-dividend date is Thursday, May 29th. This is a 137.7% increase from Advanced Medical Solutions Group's previous dividend of $0.77. The official announcement can be viewed at this link.

Advanced Medical Solutions Group Price Performance

AMS stock traded up GBX 5.60 ($0.07) during mid-day trading on Tuesday, hitting GBX 202 ($2.62). 4,321,093 shares of the stock were exchanged, compared to its average volume of 938,395. The business has a fifty day moving average price of GBX 211.47 and a 200 day moving average price of GBX 211.52. Advanced Medical Solutions Group has a 12 month low of GBX 176.60 ($2.29) and a 12 month high of GBX 275.83 ($3.57). The company has a debt-to-equity ratio of 37.01, a current ratio of 8.39 and a quick ratio of 4.58. The stock has a market capitalization of £436.17 million, a price-to-earnings ratio of 39.14, a PEG ratio of 5.00 and a beta of 0.74.

Advanced Medical Solutions Group (LON:AMS - Get Free Report) last announced its quarterly earnings data on Thursday, March 20th. The company reported GBX 10.65 ($0.14) earnings per share for the quarter. Advanced Medical Solutions Group had a return on equity of 4.57% and a net margin of 8.49%. On average, sell-side analysts anticipate that Advanced Medical Solutions Group will post 9.8159509 EPS for the current year.

Analyst Ratings Changes

Separately, Berenberg Bank reaffirmed a "buy" rating and issued a GBX 300 ($3.88) price objective on shares of Advanced Medical Solutions Group in a research note on Wednesday, March 19th.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.